Report Categories
View AllRecent Articles
View All
EOG Resources Sees Strong Q1 Gains Amid Favorable Oil Market Conditions
TD Cowen and RBC Capital Markets Adjust Home Depot Price Targets Following Solid Q1 Execution
Japan and China Trade Ministers Hold First Bilateral Chat Since Dispute at APEC Summit
Australian Stocks Close Higher as SPASX 200 Gains 069
Mixed Session as Consumer Stocks Prop Up SP 500 Tech and Energy Falter
QH Q4 2021 Earnings Massive EPS Miss Highlights Operational Challenges
DLX Q1 2026 Earnings Strong EPS Beat Amidst Ongoing Strategic Transformation
IRIX Q1 2026 Earnings NarrowerThanExpected Loss Marks Positive Surprise
BDN Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Higher
BLMN Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency
Pure Cycle PCYO Edges Lower Amid Quiet Trading Key Support Levels in Focus
Genenta Science GNTA Dips 169 Nearing Key Support at 055
TScan Therapeutics TCRX Rallies 39 as Shares Test Key Resistance Levels
Cantaloupe Inc CTLP Holds Steady at 1120 as Traders Eye Key Support and Resistance Levels
GameStop CEO Highlights Questions Over eBays 24 Billion Annual Marketing Expenditure
Jamie Dimon Signals Challenging Outlook for JPMorgan Workforce
Trainline Raises FullYear Guidance for Second Time in 2026 Citing Strong Demand
Diversified Equity Mix May Outperform Broader Nifty 500 Analysis
External Links
SpaceXs Starship Central to Valuation Early Investor Suggests Frontier Markets Await
Marten Transport Q1 2026 Earnings Small EPS Beat Amidst Challenging Freight Environment
Proficient Auto Logistics PAL Holds Near Support After Slight Decline
NextNav Inc NN Edges Higher Stock Tests Key Resistance at 2265
XOMA Royalty Holds Near Support Following Minor Decline
Meshflow Acquisition Corp Warrants MESHW Hold Steady Near Support as Trading Activity Remains Muted
MARA Holdings Bounces Off Support Testing Resistance at 145
SandRidge Energy Edges Lower as Resistance Holds SD
Coda Octopus Group CODA Surges 4 Breaks Above Key Support in Heavy Trading
Ernexa Therapeutics ERNA Slides 25 as Weakness Persists Near Support Levels